The effects of the CDK inhibitor seliciclib alone or in combination with cisplatin in human uterine sarcoma cell lines

HM Coley; CF Shotton; MI Kokkinos; H Thomas

doi:10.1016/j.ygyno.2007.01.004

Back

Journal article

The effects of the CDK inhibitor seliciclib alone or in combination with cisplatin in human uterine sarcoma cell lines

HM Coley, CF Shotton, MI Kokkinos and H Thomas

GYNECOLOGIC ONCOLOGY, Vol.105(2), pp.462-469

01/05/2007

DOI: https://doi.org/10.1016/j.ygyno.2007.01.004

Abstract

Science & Technology

Life Sciences & Biomedicine

Oncology

Obstetrics & Gynecology

OBSTETRICS & GYNECOLOGY

ONCOLOGY

uterine sarcoma

seliciclib

CYC202

roscovitine

CDK inhibition

cisplatin

combination therapy

apoptosis

GYNECOLOGIC-ONCOLOGY-GROUP

CYC202 R-ROSCOVITINE

SOFT-TISSUE SARCOMAS

NUCLEAR ACCUMULATION

CYCLIN D1

P53

EXPRESSION

DOCETAXEL

MITOMYCIN

Files and links (1)

url

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000246216800030&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11d2a86992e85fb529977dad66a846d5View

Author

Metrics

19 Record Views

19 Times Cited - Web of Science

Details

Title: The effects of the CDK inhibitor seliciclib alone or in combination with cisplatin in human uterine sarcoma cell lines
Creators: HM Coley
CF Shotton
MI Kokkinos
H Thomas
Publication Details: GYNECOLOGIC ONCOLOGY, Vol.105(2), pp.462-469
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCE
Date published: 01/05/2007
Date submitted: 17/05/2017
Identifiers: 99512312502346
Academic Unit: University of Surrey
Language: English
Resource Type: Journal article

The effects of the CDK inhibitor seliciclib alone or in combination with cisplatin in human uterine sarcoma cell lines

Abstract

Files and links (1)

Metrics

Details

Usage Policy